OA10195A - Carbazole derivatives with 17 20-lyase-inhibiting activity - Google Patents
Carbazole derivatives with 17 20-lyase-inhibiting activity Download PDFInfo
- Publication number
- OA10195A OA10195A OA60742A OA60742A OA10195A OA 10195 A OA10195 A OA 10195A OA 60742 A OA60742 A OA 60742A OA 60742 A OA60742 A OA 60742A OA 10195 A OA10195 A OA 10195A
- Authority
- OA
- OAPI
- Prior art keywords
- compound
- formula
- group
- daims
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
OA10195A true OA10195A (en) | 1996-12-18 |
Family
ID=10736007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA60742A OA10195A (en) | 1993-05-21 | 1995-11-17 | Carbazole derivatives with 17 20-lyase-inhibiting activity |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0699196A1 (fi) |
JP (1) | JPH08510455A (fi) |
CN (1) | CN1126473A (fi) |
AU (1) | AU6928794A (fi) |
BG (1) | BG100154A (fi) |
CA (1) | CA2162921A1 (fi) |
CZ (1) | CZ305195A3 (fi) |
FI (1) | FI955587A0 (fi) |
GB (1) | GB9310635D0 (fi) |
HU (1) | HUT73790A (fi) |
IL (1) | IL109703A0 (fi) |
NO (1) | NO954681D0 (fi) |
OA (1) | OA10195A (fi) |
PE (1) | PE31195A1 (fi) |
PL (1) | PL311702A1 (fi) |
SK (1) | SK142495A3 (fi) |
TW (1) | TW279866B (fi) |
WO (1) | WO1994027989A1 (fi) |
ZA (1) | ZA943494B (fi) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807880A (en) * | 1993-09-30 | 1998-09-15 | Yamanouchi Pharmaceutical Co., Ltd. | Azole derivative and pharmaceutical composition thereof |
AU3846395A (en) * | 1994-11-07 | 1996-05-31 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
EP0820989A4 (en) * | 1995-03-01 | 1998-05-06 | Yamanouchi Pharma Co Ltd | IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION BASED ON SAID DERIVATIVES |
EP0974584B1 (en) * | 1997-02-21 | 2003-01-15 | Takeda Chemical Industries, Ltd. | Fused ring compounds, process for producing the same and use thereof |
TWI306099B (en) | 2000-11-17 | 2009-02-11 | Takeda Chemical Industries Ltd | Novel imidazole derivatives, production method thereof and use thereof |
CA2429437A1 (en) | 2000-11-20 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Imidazole derivatives, process for their preparation and their use |
WO2002046186A1 (fr) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Dérivés thiazole substitués porteurs de groupes 3-pyridyl, procédé d'élaboration et leur utilisation |
CA2612723A1 (en) * | 2005-06-24 | 2007-01-04 | Eli Lilly And Company | Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
GB0525323D0 (en) * | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
GEP20156250B (en) | 2009-06-26 | 2015-02-25 | Novartis Ag | 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
BR112012019551A2 (pt) * | 2010-02-04 | 2016-08-09 | Radius Health Inc | moduladores seletivos do receptor de androgênio. |
CA2799183A1 (en) | 2010-05-12 | 2011-11-17 | Radius Health, Inc. | Therapeutic regimens |
JP5998137B2 (ja) | 2010-08-04 | 2016-09-28 | ペルフィキュア ファーマシューティカルズ,インコーポレイテッド | 前立腺癌を処置するための併用療法 |
WO2012035078A1 (en) | 2010-09-16 | 2012-03-22 | Novartis Ag | 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS |
JP5965909B2 (ja) | 2010-09-28 | 2016-08-10 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
EA023064B1 (ru) | 2011-04-28 | 2016-04-29 | Новартис Аг | ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ |
US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
WO2014158875A1 (en) | 2013-03-14 | 2014-10-02 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
HUE061499T2 (hu) | 2014-03-28 | 2023-07-28 | Univ Duke | Mellrák kezelése szelektív ösztrogénreceptor-módosítók alkalmazásával |
EP3191087A1 (en) | 2014-09-12 | 2017-07-19 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
AU2017281038B2 (en) | 2016-06-22 | 2021-09-09 | Ellipses Pharma Ltd | AR+ breast cancer treatment methods |
EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
KR20230109795A (ko) | 2017-01-05 | 2023-07-20 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Application Discontinuation
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A0/fi not_active Application Discontinuation
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG100154A (en) | 1996-07-31 |
GB9310635D0 (en) | 1993-07-07 |
TW279866B (fi) | 1996-07-01 |
PL311702A1 (en) | 1996-03-04 |
HUT73790A (en) | 1996-09-30 |
CA2162921A1 (en) | 1994-12-08 |
EP0699196A1 (en) | 1996-03-06 |
CZ305195A3 (en) | 1996-06-12 |
IL109703A0 (en) | 1994-08-26 |
FI955587A (fi) | 1995-11-20 |
SK142495A3 (en) | 1996-06-05 |
PE31195A1 (es) | 1995-10-18 |
ZA943494B (en) | 1995-01-23 |
CN1126473A (zh) | 1996-07-10 |
HU9503321D0 (en) | 1996-01-29 |
JPH08510455A (ja) | 1996-11-05 |
FI955587A0 (fi) | 1995-11-20 |
WO1994027989A1 (en) | 1994-12-08 |
NO954681L (no) | 1995-11-20 |
AU6928794A (en) | 1994-12-20 |
NO954681D0 (no) | 1995-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA10195A (en) | Carbazole derivatives with 17 20-lyase-inhibiting activity | |
EP1373224B1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
IE904146A1 (en) | Indole Derivatives | |
CA2553345C (en) | Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 | |
AU2014300894A1 (en) | Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase | |
SU1549485A3 (ru) | Способ получени производных 6-метиленандроста-1,4-диен-3,17-диона | |
JP2707936B2 (ja) | β−オキソ−β−ベンゼンプロパンチオアミド誘導体 | |
Stamm et al. | Reactions with aziridines. 48. Friedel-Crafts reactions with N-sulfonated aziridines and with open-chain sulfonamides. Sulfonamides as leaving groups in open-chain structures | |
CA2214744C (en) | 3-(bis-substituted phenylmethylene)oxindole derivatives | |
KR19980702319A (ko) | 이미다졸 유도체 및 이의 의약 조성물 | |
US5578630A (en) | Heterocyclic compounds which inhibit aromatase | |
Branchaud | Studies on the development of the tritylsulfenyl group as a nitrogen protecting group and application in a synthesis of. delta.-coniceine | |
US6689798B2 (en) | Benzofuran derivatives | |
EP0240263B1 (en) | Indenopyrimidine derivatives | |
DK149469B (da) | 3,5-disubstitueret 1h-1,2,4-triazolderivat til anvendelse som antireproduktivt middel | |
HU229135B1 (en) | Benzofurane derivatives | |
JP5054882B2 (ja) | テトラヒドロベンズフルオレン誘導体 | |
KR102406248B1 (ko) | Hsp90 억제제로서의 1,2,3-트리아졸 유도체 화합물 | |
HU191597B (en) | Process for producing of 2-/2-indalin/-imadazoline preparates and medical preparates consisting of such substances | |
HUT59107A (en) | Process for producing new 4(5)-imidazole derivatives having aromatase inhibiting activity and pharmaceutical compositions comprising same as active ingredient | |
US4064177A (en) | 3-Alkoxy-D-homo-C-nor-13α, 14α-gona-1,3,5,(10),6,8-pentaen-17-one and derivatives thereof | |
JPS6256471A (ja) | 含窒素四環式化合物 | |
JP2002030063A (ja) | スルファメート化合物の製造方法 | |
EP0654265A1 (en) | Aromatase-inhibiting composition containing azole derivative | |
JPS6172763A (ja) | プレニルベンズイミダゾ−ル誘導体および抗潰瘍剤 |